Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy (Q42430831)
Jump to navigation
Jump to search
scientific article published on 13 August 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy |
scientific article published on 13 August 2012 |
Statements
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy (English)
Bonaventura Clotet
David Dalmau
José Antonio Iribarren
Estrella Caballero
Josep Maria Llibre
José López Aldeguer
Pompeyo Viciana
Celia Miralles
Antonio Ocampo
Lourdes Anta
Juan Luis Gómez Sirvent
Resistance Platform of the Spanish AIDS Research Network (ResRIS)
Jorge del Romero
Gilberto Betancor
María Nevot
José L Blanco
Carmen de Mendoza
Angels Jaén
José María Gatel
Carmen Vidal
Melchor Riera
Juan Córdoba
María José Galindo
Félix Gutiérrez
Marta Álvarez
Federico García
Pilar Pérez-Romero
Manuel Leal
José Carlos Palomares
Isabel Viciana
Jesús Santos
Patricia Rodríguez
Carolina Gutiérrez
Santiago Moreno
Carmen Rodríguez
Angelina Cañizares
José Pedreira
Luis Morano
Carolina Garrido
Gustavo Manuzza
Francesc Vidal
13 August 2012
2 references
Identifiers
1 reference